Howard Bernstein left Acusphere to pursue new opportunities, the company said. He was instrumental in developing Acusphere's core microsphere technology platform and in devising ways to apply the technology to new and existing drugs, such as Imagify, the company's lead product candidate, which is currently awaiting approval by the U.S. Food and Drug Administration (FDA).
Acusphere's Imagify to get FDA review, October 13, 2008
Acusphere taps new VP, September 25, 2008
Acusphere receives Nasdaq noncompliance notice, August 14, 2008
Acusphere reports Q2 results, August 12, 2008
Acusphere cuts staff, July 29, 2008
Copyright © 2008 AuntMinnie.com